Fig. 3From: Tanshinone IIA prevents platelet activation and down-regulates CD36 and MKK4/JNK2 signaling pathwayEffect of TanshinoneIIA (TS IIA) on platelet CD36 level and platelet activation. Quantification of flow cytometry of platelets incubated with serial concentrations of TS IIA for 15 min before stimulation with 10 μg/mL PMVs, then CD36 MFI a and PAC-1 positivity b was measured. Data are means ± SD (n = 4). * P < 0.05 compared with untreated control. # P < 0.05 compared with PMV treatmentBack to article page